The most frequent events are amplification of receptor tyrosine kinases and mutations of the genes CDKN2A/p16, SUZ12, TP53, and PTEN. One or more are considered necessary in the development of an MPNST [19–24]. The gene discussed is CDKN2A; the disease is malignant peripheral nerve sheath tumor.